Looking at the linked post, this paragraph jumps out at me:
I’ve now talked to some pretty well-qualified bio PHDs with expertise in stem cells, gene therapy, and genetics. While many of them were skeptical, none of them could point to any part of the proposed treatment process that definitely won’t work. The two areas they were most skeptical of was the ability to deliver an editing vector to the brain and the ability to perform many edits in the same cell. But both seem addressable. Delivery for one, may be solved by other scientists trying to deliver gene editors to the brain to target monogenic conditions like Huntington’s.
Ignoring the spin, what this paragraph actually says is “I sent this proposal to a bunch of experts and they said it probably wouldn’t work”. So my guess is to why nobody is funding this is that it probably wouldn’t work.
Looking at the linked post, this paragraph jumps out at me:
Ignoring the spin, what this paragraph actually says is “I sent this proposal to a bunch of experts and they said it probably wouldn’t work”. So my guess is to why nobody is funding this is that it probably wouldn’t work.